Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

New hair loss treatments could be improved by using combined biological markers.

Plucked hair follicles can help diagnose scalp lupus.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

ITK inhibitors may effectively treat alopecia areata.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Entospletinib effectively prevents eye and skin GVHD in mice.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

A new mouse model effectively mimics vitiligo for research and drug testing.

Transplant success has improved with better immunosuppressive drugs and donor matching.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Erianin may effectively treat alopecia areata by targeting the immune system.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Deleting Snai2 and Snai3 causes fatal autoimmunity.